On July 10, 2020, Valeo Pharma Inc. (CNSX:VPH) closed the transaction. The company has issued 1,700 unsecured non-convertible debenture units for gross proceeds of CAD 1,700,000 in the transaction. The transaction included participation from Manitex Capital Inc., Senior Executives, staff members, and 3 directors of the company for an aggregate amount of CAD 390,000.

The securities issued under the transaction are subject to a four-month hold period in accordance with applicable securities legislation. The company has paid CAD 36,250 as finder's fees to arm's-length parties in connection with the transaction, in compliance with applicable securities laws. No other broker or agent was involved in the transaction.